These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26705099)

  • 1. Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.
    Burghuber CK; Kwun J; Page EJ; Manook M; Gibby AC; Leopardi FV; Song M; Farris AB; Hong JJ; Villinger F; Adams AB; Iwakoshi NN; Knechtle SJ
    Am J Transplant; 2016 Jun; 16(6):1726-38. PubMed ID: 26705099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.
    Kim EJ; Kwun J; Gibby AC; Hong JJ; Farris AB; Iwakoshi NN; Villinger F; Kirk AD; Knechtle SJ
    Am J Transplant; 2014 Jan; 14(1):59-69. PubMed ID: 24354871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model.
    Schroder PM; Schmitz R; Fitch ZW; Ezekian B; Yoon J; Choi AY; Manook M; Barbas A; Leopardi F; Song M; Farris AB; Collins B; Kwun J; Knechtle SJ
    Kidney Int; 2021 Jan; 99(1):161-172. PubMed ID: 32898569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
    Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates.
    Schmitz R; Fitch ZW; Manook M; Schroder PM; Choi AY; Olaso D; Yoon J; Bae Y; Shaw BI; Song M; Kuchibhatla M; Farris AB; Kirk A; Kwun J; Knechtle SJ
    Kidney360; 2022 Dec; 3(12):2116-2130. PubMed ID: 36591367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients.
    Burghuber CK; Manook M; Ezekian B; Gibby AC; Leopardi FV; Song M; Jenks J; Saccoccio F; Permar S; Farris AB; Iwakoshi NN; Kwun J; Knechtle SJ
    Am J Transplant; 2019 Mar; 19(3):724-736. PubMed ID: 30102844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose.
    Steines L; Poth H; Schuster A; Amann K; Banas B; Bergler T
    Front Immunol; 2021; 12():657894. PubMed ID: 34135891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.
    Kwun J; Page E; Hong JJ; Gibby A; Yoon J; Farris AB; Villinger F; Knechtle S
    Am J Transplant; 2015 Mar; 15(3):815-22. PubMed ID: 25675879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Rabbit Antithymocyte Globulin on Acute and Chronic Active Antibody-Mediated Rejection After Kidney Transplantation.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
    Transplant Proc; 2019 Oct; 51(8):2602-2605. PubMed ID: 31324482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
    Yang TY; Sun Y; Langnas AN; Zhao Y
    Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.
    Manook M; Flores WJ; Schmitz R; Fitch Z; Yoon J; Bae Y; Shaw B; Kirk A; Harnois M; Permar S; Farris AB; Magnani DM; Kwun J; Knechtle S
    Front Immunol; 2021; 12():660900. PubMed ID: 34149698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of immunosuppressive drugs on circulating Tfh cells in kidney transplant recipients: A pilot study.
    Li YM; Li Y; Shi YY; Yan L; Wu XJ; Tang JT; Bai YJ; Wang LL
    Transpl Immunol; 2018 Feb; 46():1-7. PubMed ID: 28974433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization.
    Choi AY; Manook M; Olaso D; Ezekian B; Park J; Freischlag K; Jackson A; Knechtle S; Kwun J
    Front Immunol; 2021; 12():694763. PubMed ID: 34177960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Filtration Plasmapheresis Plus Low-Dose Anti-thymocyte Globulin and Tacrolimus in Asian Living-Donor Kidney Transplantation With Donor-Specific Anti-HLA Antibody.
    Kantachuvesiri S; Ingsathit A; Thammanichanond D; Choochaeam K; Sra-Ium S; Kitiyakara C; Nongnuch A; Sakulchairungrueng B; Worawichawong S
    Transplant Proc; 2021 Apr; 53(3):995-1000. PubMed ID: 32948312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR5
    Danger R; Chesneau M; Delbos F; Le Bot S; Kerleau C; Chenouard A; Ville S; Degauque N; Conchon S; Cesbron A; Giral M; Brouard S
    Front Immunol; 2019; 10():2071. PubMed ID: 31552030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.